The University of Chicago Header Logo

Connection

Olwen Hahn to Incidence

Back to Details
This is a "connection" page, showing publications Olwen Hahn has written about Incidence.
Olwen Hahn
Connection Strength
0.029
Incidence
  1. Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study. Breast Cancer Res Treat. 2018 Sep; 171(2):325-334.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.